Rigel Pharmaceuticals
RIGL
RIGL
117 hedge funds and large institutions have $490M invested in Rigel Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 44 increasing their positions, 31 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $528M → $490M (-$37.5M)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
117
Holding in Top 10
–
Calls
$8.8M
Puts
$5.09M
Top Buyers
| 1 | +$7.08M | |
| 2 | +$3.58M | |
| 3 | +$2.87M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.45M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.31M |
Top Sellers
| 1 | -$5.54M | |
| 2 | -$3.43M | |
| 3 | -$3.24M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$3.2M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.61M |